Money Moderna stock falls more than 10% as it slashes guidance on low EU sales, tough U.S. vaccine market 2 mins read Moderna on Thursday reported second-quarter revenue that beat expectations but slashed its full-year sales
Money Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold 3 mins read Moderna on Thursday posted a narrower-than-envisioned reduction for the 1st quarter as the firm’s
Finanance Stocks making the biggest premarket moves: Tesla, Moderna, Alphabet, PacWest and more 1 min read These are the shares putting up the premier moves in the premarket. Supply link